AstraZeneca Appeals IRA Loss, Reiterates Constitutional Challenge to Drug Price Negotiations

AstraZeneca joins Johnson & Johnson and Bristol Myers Squibb in appealing a previous legal loss for its challenge to the government’s drug price-setting program.